Deferasirox Reduces Iron Burden in Aplastic Anemia
This is a discussion on Deferasirox Reduces Iron Burden in Aplastic Anemia within the Other Clinical Pharmacy News forum, part of the Industry News and Updates category; Oral therapy with the iron-chelating agent deferasirox (Exjade) is effective in patients with aplastic anemia, researchers report in a ...
|
|||||||
| Register | Help | Members List | Mark Forums Read |
07-12-2010, 02:26 PM
|
|||
|
|||
Deferasirox Reduces Iron Burden in Aplastic Anemia
Oral therapy with the iron-chelating agent deferasirox (Exjade) is effective in patients with aplastic anemia, researchers report in a June 21st online paper in Blood.
Reuters Health Information More... 
|
 |
«
Previous Thread
|
Next Thread
»
| Thread Tools | |
| Display Modes | |
Linear Mode
|
|
|
||||
| Thread | Thread Starter | Forum | Replies | Last Post |
| New Boxed Warning for Deferasirox | industry_news | Other Clinical Pharmacy News | 0 | 02-18-2010 08:13 PM |
| Oral Chemotherapy Poses Financial Burden to Patients | industry_news | Other Clinical Pharmacy News | 0 | 05-07-2009 08:32 PM |
| IV Iron Added to ESAs Improves Results in Chemotherapy-Induced Anemia | industry_news | Other Clinical Pharmacy News | 0 | 09-15-2008 03:19 PM |
| COPD in Asthma Patients Adds Significantly to Disease Burden | industry_news | Other Clinical Pharmacy News | 0 | 08-09-2008 08:41 AM |
© 2008 DrugManagementForum™ powered by |
 |